Lung Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. Our lung cancer clinical trials give patients access to new and innovative treatments.

Current clinical trials often include studies for non small cell lung cancer and innovative immunotherapy approaches.

Learn more about participating in a clinical trial at Norton Healthcare.

Active lung cancer clinical trials at Norton Cancer Institute include:

Lung Cancer/ Breast Cancer

A Phase 1 Study to evaluate the safety, pharmacokinetics, and pharmacodynamics of escalating doses and treatment intensification of a vaccine-based immunotherapy Regimen-2 (VBIR-2) (PF-06936308) for advanced non-small cell lung cancer and metastatic triple-negative breast cancer

Non-Small Cell Lung Cancer (NSCLC)

LUNAR: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields)in combination with PD-1 inhibitors or docetaxel, for second line treatment of non-small cell lung cancer (NSCLC)

Non-Small Cell Lung Cancer (NSCLC)

MAINTENANCE SYSTEMIC THERAPY VERSUS CONSOLIDATIVE STEREOTACTIC BODY RADIATION THERAPY (SBRT) PLUS MAINTENANCE SYSTEMIC THERAPY FOR LIMITED METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A RANDOMIZED PHASE II/III TRIAL

Non-Small Cell Lung Cancer (NSCLC)

A Pilot, Open-Label, Multi-Center, Multi-Dose Study of GRN-1201 Added to Pembrolizumab in Subjects with PD-L1+ Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

A Phase II, Multicenter, Randomized, Open-Label, Controlled Study of M7824 versus Pembrolizumab as a First line Treatment in Patients with PD-L1 Expressing Advanced Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

A Phase 2, Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab Alone or in Combination with Novel Agents in Subjects with Locally Advanced, Unresectable, Stage III Non-small Cell Lung Cancer (COAST)

Pulmonary Nodules

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04

Small Cell Carcinoma

REPLATINUM: A Phase 3, Controlled, Open-label, Randomized Study of RRx-001 Administered Sequentially with a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Carcinoma

Small Cell Lung Cancer (SCLC)

A Phase 1 Dose Escalation and Expanded Cohort Study of PF-06821497 in the treatment of adult patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC), and Follicular Lymphoma (FL)

Solid Tumors

Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Cokie Roberts’ 17-year breast cancer survival points to medical advances

When television journalist Cokie Roberts was diagnosed with breast cancer in 2002, she had reason to be optimistic. The 15-year survival rate for breast cancer patients was about 70%, meaning the odds were with her, […]

Read Full Story

Using vaccines to treat brain cancer: 4 things to know about this immunotherapy trial

Immunotherapy is a method of treating cancer, and new immune treatments are being studied across the country. Norton Cancer Institute is participating in a clinical trial conducted by AIVITA Biomedical Inc. to study whether a […]

Read Full Story

Why do I ride in Bike to Beat Cancer? Because I miss you, Rhonda

Ever have that work friend that turns into a real friend? Rhonda Hoffman was that real friend. We met not long after I moved here from Cincinnati for a career change. After several years, we […]

Read Full Story

Thomas M. Woodcock, M.D., to retire; pioneered cancer care in Louisville and Southern Indiana

Thomas M. Woodcock, M.D., came to Louisville in 1981 and was one of four founders of what is now Norton Cancer Institute. After almost 40 years as a medical oncologist, Dr. Woodcock plans to retire […]

Read Full Story

New dad gets ependymoma brain tumor diagnosis one day after son’s birth

March 2016 was a life-changing time for the Davis family. On March 23, Matt Davis and his wife, Hailey, celebrated the birth of their son, Finley. The next day, Matt learned he had a rare […]

Read Full Story
Related Stories

Cokie Roberts’ 17-year breast cancer survival points to medical advances

When television journalist Cokie Roberts was diagnosed with breast cancer in 2002, she had reason to be optimistic. The 15-year survival rate for breast cancer patients was about 70%, meaning the odds were with her, […]

Read Full Story

Using vaccines to treat brain cancer: 4 things to know about this immunotherapy trial

Immunotherapy is a method of treating cancer, and new immune treatments are being studied across the country. Norton Cancer Institute is participating in a clinical trial conducted by AIVITA Biomedical Inc. to study whether a […]

Read Full Story

Why do I ride in Bike to Beat Cancer? Because I miss you, Rhonda

Ever have that work friend that turns into a real friend? Rhonda Hoffman was that real friend. We met not long after I moved here from Cincinnati for a career change. After several years, we […]

Read Full Story

Thomas M. Woodcock, M.D., to retire; pioneered cancer care in Louisville and Southern Indiana

Thomas M. Woodcock, M.D., came to Louisville in 1981 and was one of four founders of what is now Norton Cancer Institute. After almost 40 years as a medical oncologist, Dr. Woodcock plans to retire […]

Read Full Story

New dad gets ependymoma brain tumor diagnosis one day after son’s birth

March 2016 was a life-changing time for the Davis family. On March 23, Matt Davis and his wife, Hailey, celebrated the birth of their son, Finley. The next day, Matt learned he had a rare […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.